Defining the Right Dose Without Individualisation: Can Clinical Pharmacology & Dosimetry Deliver More Predictable Radioligand Therapy Outcomes?

Name: Defining the Right Dose Without Individualisation: Can Clinical Pharmacology & Dosimetry Deliver More Predictable Radioligand Therapy Outcomes?
Start: 2026-12-02T13:30
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 13:30

Defining the Right Dose Without Individualisation: Can Clinical Pharmacology & Dosimetry Deliver More Predictable Radioligand Therapy Outcomes? was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 1 speaker on record.

Speakers

Shefali Kakar — Speaker Vice President, Global Head PK Sciences - Oncology, Novartis AG